Table 1.
Clinical characteristics in white and black patients from SEER and diagnosed between 1991 and 2010 with endometrial cancer, endometrioid endometrial cancer or non-endometrioid endometrial cancer.
| Histologic Cell Type | ||||||
|---|---|---|---|---|---|---|
| All Histologic Cell Typesa,d | Endometrioidb,d | Non-endometrioidc,d | ||||
| White (N = 78,184) | Black (N = 8518) | White (N = 54,423) | Black (N = 4163) | White (N = 16,727) | Black (N = 3626) | |
| Age (years) | ||||||
| Median (IQR) | 64 (56–73) | 64 (57–72) | 62(55–72) | 61 (54–69) | 68 (60–77) | 66(60–73) |
| < 50 | 8469 (10.8) | 920 (10.8) | 6573 (12.1) | 689 (16.6) | 1103 (6.6) | 161 (4.4) |
| 50–54 | 8665 (11.1) | 707 (8.3) | 6753 (12.4) | 455 (10.9) | 1132 (6.8) | 193 (5.3) |
| 55–59 | 12,012 (15.4) | 1158 (13.6) | 9017 (16.6) | 639 (15.4) | 1898 (11.4) | 428 (11.8) |
| 60–64 | 11,956 (15.3) | 1627 (19.1) | 8603 (15.8) | 771 (18.5) | 2330 (13.9) | 742 (20.5) |
| 65–69 | 10,639 (13.6) | 1437 (16.9) | 7208 (13.2) | 604 (14.5) | 2596 (15.5) | 709 (19.6) |
| 70–74 | 9068 (11.6) | 1133 (13.3) | 5842 (10.7) | 435 (10.5) | 2504 (15.0) | 620 (17.1) |
| 75–79 | 7696 (9.8) | 822 (9.7) | 4839 (8.9) | 322 (7.7) | 2243 (13.4) | 411 (11.3) |
| ≥ 80 | 9679 (12.4) | 714 (8.4) | 5588 (10.3) | 248 (6.0) | 2921 (17.5) | 362 (10.0) |
| Cell Type | ||||||
| Endometrioid | 60,899 (77.9) | 4710 (55.3) | 54,423 (100) | 4163 (100) | - | - |
| Grade 1 | 26,850 (49.3) | 1614 (38.8) | - | - | ||
| Grade 2 | 19,234 (35.3) | 1488 (35.7) | - | - | ||
| Grade 3 | 8339 (15.3) | 1061 (25.5) | - | - | ||
| Serous | 5951 (7.6) | 1536 (18.0) | - | - | 5742 (34.3) | 1471 (40.6) |
| Mixed | 5190 (6.6) | 519 (6.1) | - | - | 5099 (30.5) | 501 (13.8) |
| Clear Cell | 1401 (1.8) | 315 (3.7) | - | - | 1331 (8.0) | 299 (8.3) |
| Carcinosarcoma | 4743 (6.1) | 1438 (16.9) | - | - | 4555 (27.2) | 1355 (37.4) |
| Stage | ||||||
| Local | 55,595 (71.1) | 4651 (54.6) | 43,373 (79.7) | 3032 (72.8) | 8278 (49.5) | 1366 (37.7) |
| Regional | 14,332 (18.3) | 2174(25.5) | 8666 (15.9) | 827 (19.9) | 4819 (28.8) | 1263 (34.8) |
| Distant | 6305 (8.1) | 1336 (15.7) | 2384 (4.4) | 304 (7.3) | 3630 (21.7) | 997 (27.5) |
| Unstaged | 1952 (2.5) | 357 (4.2) | - | - | - | - |
| Year of Diagnosis | ||||||
| 1991–2000 | 16,899 (21.6) | 1642 (19.3) | 11,119 (20.4) | 662 (15.9) | 4682 (28.0) | 828 (22.8) |
| 2001–2010 | 61,285 (78.4) | 6876 (80.7) | 43,304 (79.6) | 3501 (84.1) | 12,045 (72.0) | 2798 (77.2) |
Bolding was used to indicate the values that were the most significantly different in black compared with white patients.
a
Patients with missing data in tumor grade or stage included for analysis of distribution in histologic subtypes.
b
Patients with missing data in tumor grade or stage were excluded.
c
Patients with missing data in stage were excluded.
d
Median age with interquartile range (IQR) at diagnosis for white vs black patients was examined using an analysis of variance test.